Search

everythinglearnresearchcommunity

for

Search:↓

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Low-potency steroids can cause serious side effects in people with skin conditions like Netherton syndrome.

Scientists in India found a safer and efficient way to make a type of medicine called hydantoins from carbamates, which also worked well in making the seizure medicine, Ethotoin.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

A new topical finasteride formulation effectively promotes hair growth with fewer side effects.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Finasteride and DEHP exposure during development can change reproductive markers in rats.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

A woman with a specific mutation causing adrenal gland issues faced fertility problems, but careful hormone therapy helped her manage it successfully.

Using β-cyclodextrin derivatives improves the solubility and bioavailability of steroidal drugs.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

The woman had a genetic condition causing high cortisol and androgen levels, treatable with dexamethasone.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

New compounds may help treat prostate issues without affecting androgen receptors.

Stopping heptaminol medication reversed hair color loss in a patient on dialysis.

Reducing 3α,5α-THP in the hippocampus increases seizures in female rats.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

GI197111X is best dissolved in Capmul MCM for trials.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.